Archive · 8 Dec 2025
Creador Acquires 7% Stake in La Renon
Creador, a private equity firm, has bought a 7% share of La Renon, a big pharma company in India.
They bought this share from Peak XV Partners.
La Renon makes medicines for things like kidney problems, brain issues, and other long-term illnesses.
They have been growing fast and now sell medicines in many countries.
Creador is happy to help La Renon grow even more.
La Renon's boss, Pankaj Singh, is also happy because this shows people believe in his company.
They make a lot of money and have many special medicine recipes that no one else has.
Creador acquired a 7% stake in La Renon Healthcare from Peak XV Partners.
La Renon is a prominent player in India's branded formulations market, focusing on chronic therapeutic segments.
The company has delivered a 25% CAGR in revenue and 30% CAGR in Ebitda over the last 10 years.
La Renon reported a revenue of ₹1,685 crore and an Ebitda of ₹356 crore in FY25.
The company holds over 250 patents worldwide and is expanding its footprint across key emerging markets.
- Who
- Creador, La Renon Healthcare, Peak XV Partners
- What
- Acquisition of 7% stake in La Renon by Creador
- When
- Monday (specific date not mentioned)
- Where
- Mumbai, India
- Why
- To partner in La Renon's growth phase and focus on high-quality healthcare and pharmaceutical companies
- Company
- La Renon Healthcare
- Acquirer
- Creador
- Stake Acquired
- 7%
- Seller
- Peak XV Partners
- Founder
- Pankaj Singh
- Revenue (FY25)
- ₹1,685 crore
- Ebitda (FY25)
- ₹356 crore
- Patents
- 250+ worldwide